drugs that reduce 5-hydroxytryptamine , dopamine , and adrenaline or increase noradrenaline neurotransmission tended to facilitate the occurrence of estrous behavior in estrogen-treated females , and drugs having opposite effects tended to inhibit receptivity induced by estrogen and progesterone .
C0014563
adrenaline
C0028351
noradrenaline